Halley E. Gilbert - 01 Jun 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: Director
Signature: Halley Gilbert, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol: PCVX
Transactions as of: 01 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 03 Jun 2022, 16:29:42 UTC
Previous filing: 03 Mar 2022
Next filing: 17 Jun 2022
SEC: View on sec.gov

Quoteable Key Fact

"Halley E. Gilbert filed Form 4 for Vaxcyte, Inc. (PCVX) on 03 Jun 2022."

Quick Takeaways

This page summarizes Halley E. Gilbert's Form 4 filing for Vaxcyte, Inc. (PCVX).
2 reported transactions and 1 derivative row are listed below.
Filing timestamp: 03 Jun 2022, 16:29.

What Changed

Previous filing in this sequence was filed on 03 Mar 2022.
Current net transaction value: $0.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Award	$0	+3,125		$0.000000	3,125	01 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Award	$0	+18,750		$0.000000	18,750	01 Jun 2022	Common Stock	18,750	$22.70	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
F2	The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Content

Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.